Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MYLK-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
HTR4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CETN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AVPR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
BAIAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTGES2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HPDL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TDP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100506691 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPIP5K1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CNBD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFITM10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP5J - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCND3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANTXR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MED24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on